Adrienne Graves

Adrienne Graves

Direttore/Membro del Consiglio presso OCULAR THERAPEUTIX, INC.

Patrimonio netto: 843 451 $ in data 31/05/2026

71 anni
Health Technology
Commercial Services
Miscellaneous

Profilo

Dr. Adrienne L.
Graves
is an Independent Director at Opus Genetics, Inc., an Independent Director at Harrow, Inc., an Independent Director at Ocular Therapeutix, Inc., an Independent Director at Qlaris Bio, Inc., a Chairman at Retinal Degeneration Fund, a Member at American Glaucoma Society, a Member at The Association for Research in Vision & Ophthalmology and a Member at Women in Ophthalmology, Inc. She is on the Board of Directors at Opus Genetics, Inc., Harrow, Inc., Osanni Bio, Inc., G-Metrics GmbH, Ocular Therapeutix, Inc., JelliSee Ophthalmics, Inc., NVasc, Inc., The Foundation Fighting Blindness, Inc., Qlaris Bio, Inc., American Academy of Ophthalmology, Inc., The American Society of Cataract & Refractive Surgery, Glaucoma Research Foundation, American Academy of Ophthalmology Foundation, American Society of Cataract & Refractive Surgery Foundation, Himalayan Cataract Project, KeepYourSight Foundation, Pan-American Ophthalmological Foundation and Retina Global.
Dr. Graves was previously employed as a Chairman by IVERIC bio, Inc., a Non-Executive Director by Oxurion NV, an Independent Director by Greenbrook TMS, Inc., an Independent Director by Surface Ophthalmics, Inc., an Independent Director by Nicox SA, an Independent Director by Akorn, Inc., an Independent Director by Aerpio Therapeutics, Inc., an Independent Director by Encore Vision, Inc., an Independent Director by Trukera Medical, a Vice President-Clinical Affairs by Santen, Inc., a Director-International Ophthalmology by Alcon Laboratories, Inc., and a Co-Founder by Ophthalmic Women Leaders.
She also served on the board at Opus Genetics, Inc. /OLD/, TherOptix, Inc., Nicox Ophthalmics, Inc., Envisia Therapeutics, Inc., Aerpio Pharmaceuticals, Inc. and Ophthalmic World Leaders.
She received her undergraduate degree from Brown University and a doctorate degree from the University of Michigan.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
20/04/2026 127.514 ( 0,16% ) 555 961 $ 31/05/2026
31/03/2026 28.000 ( 0,01% ) 252 280 $ 31/05/2026
18/05/2026 1.000 ( 0% ) 35 210 $ 31/05/2026

Posizioni attive di Adrienne Graves

SocietàPosizioneInizio
OCULAR THERAPEUTIX, INC. Direttore/Membro del Consiglio 10/07/2023
HARROW, INC. Direttore/Membro del Consiglio 26/01/2024
OPUS GENETICS, INC. Direttore/Membro del Consiglio 22/10/2024
Retina Global
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio 01/01/2023
Presidente 21/07/2022
Direttore/Membro del Consiglio 01/01/2021

Precedenti posizioni note di Adrienne Graves

SocietàPosizioneFine
NICOX SA Direttore/Membro del Consiglio 27/02/2024
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Adrienne Graves

Formazione di Adrienne Graves

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

69

Relazioni di 1° grado

40

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private40

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Pan-American Ophthalmological Foundation

Commercial Services

Commercial Services

Miscellaneous

Commercial Services

Ophthalmic Women Leaders

Health Technology

Health Technology

Commercial Services

American Academy of Ophthalmology Foundation

Commercial Services

Electronic Technology

Health Services

Miscellaneous

Commercial Services

Health Technology

Health Technology

Health Services

Health Technology

Miscellaneous

Health Technology

Electronic Technology

Health Technology

Health Technology

Retina Global

Commercial Services

Health Technology

Ophthalmic World Leaders

Commercial Services

  1. Mercati
  2. Insiders
  3. Adrienne Graves
- 40% : I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA